Replimune (REPL) Non Operating Income (2017 - 2026)
Replimune (REPL) reported Non Operating Income of -$119000.0 for Q1 2026, down 102.34% on a YoY basis from $5.1 million in Q1 2025, and down 118.98% sequentially from $627000.0 in Q4 2025.
Replimune (REPL) Non Operating Income (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Non Operating Income data on file, last reported at -$119000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 102.34% year-over-year to -$119000.0; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 63.33% YoY), and the FY2026 full-year result was $5.4 million, down 63.32% from the prior year.
- Non Operating Income slipped to -$119000.0 in Q1 2026, from $627000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $6.3 million in Q2 2023 to a low of -$1.5 million in Q3 2022.
- A 5-year average of $2.5 million and a median of $3.6 million in 2023 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 7983.33% in 2022, while the deepest fall reached 2067.14% in 2022.
- Tracing REPL's Non Operating Income over 5 years: stood at $1.9 million in 2022, then jumped by 203.76% to $5.9 million in 2023, then slumped by 95.69% to $254000.0 in 2024, then jumped by 146.85% to $627000.0 in 2025, then plunged by 118.98% to -$119000.0 in 2026.
- Business Quant data shows REPL's Non Operating Income at -$119000.0 in Q1 2026, $627000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | -119,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119,000.00 |
| Dec 31, 2025 | 627,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 5.89 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | -1.52 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | -108,000.00 |
| Jun 30, 2021 | 70,000.00 |